{"gene":"PAH","run_date":"2026-06-10T05:19:53","timeline":{"discoveries":[{"year":2007,"finding":"PAH enzyme (phenylalanine hydroxylase) catalyzes the conversion of L-phenylalanine to tyrosine in the presence of molecular oxygen and the nonprotein cofactor tetrahydrobiopterin (BH4); loss-of-function mutations (>500 alleles) in the PAH gene cause hyperphenylalaninemia and phenylketonuria.","method":"Review synthesizing established biochemical assays and genetic studies; enzymatic activity (EC 1.14.16.1) documented across decades of in vitro and in vivo work","journal":"Human mutation","confidence":"High","confidence_rationale":"Tier 1 / Strong — enzymatic mechanism reconstituted and replicated across many independent laboratories over decades; cofactor requirements established by in vitro assay","pmids":["17443661"],"is_preprint":false},{"year":2003,"finding":"In vitro expression analysis of 81 PAH mutations established that the predominant pathogenic mechanism is amino acid substitution-induced misfolding of the PAH monomer and/or failure to assemble into the native homotetramer, leading to accelerated cellular degradation and reduced intracellular steady-state enzyme levels, thereby decreasing phenylalanine hydroxylation.","method":"In vitro expression in multiple eukaryotic cell systems (COS-7 and others), quantification of residual enzyme activity and protein levels for 81 distinct PAH missense and other mutations","journal":"Human mutation","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — direct in vitro expression assays with multiple mutations across multiple systems, replicated across independent labs summarized in curated database","pmids":["12655545"],"is_preprint":false},{"year":2001,"finding":"In vitro eukaryotic expression (pCDNA3/COS-7 system) of three PAH missense mutations (L41F, T92I, P211T) demonstrated residual PAH enzyme activities of 10%, 76%, and 72% of normal, respectively, confirming their pathogenicity and establishing a correlation between in vitro residual activity and clinical metabolic phenotype severity.","method":"Eukaryotic expression system (pCDNA3/COS-7), enzymatic activity assay for mutant PAH proteins","journal":"Molecular genetics and metabolism","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — direct in vitro enzymatic assay with mutagenesis, but single lab with limited number of mutations","pmids":["11708866"],"is_preprint":false},{"year":2001,"finding":"A splice-site mutation at the invariant GT dinucleotide of the exon 11 intron 11 boundary (T→G transversion, equivalent to human c.1199+2T>G) in the mouse Pah gene ablates normal splicing and activates two cryptic splice donor sites, generating transcripts with a 5-nt insertion or 5-nt deletion that cause frameshifting in exons 12–13 and premature termination, resulting in PAH deficiency.","method":"cDNA sequencing of mutant transcripts, genomic sequencing of splice site, characterization of aberrant splicing products in PAHenu3 mouse model","journal":"Molecular genetics and metabolism","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct sequencing of mutant allele and transcripts with identification of cryptic splice sites; functional consequence (hyperphenylalaninemia) confirmed in vivo in mouse model","pmids":["11161825"],"is_preprint":false},{"year":2016,"finding":"CRISPR RNA-guided FokI-dCas9 nucleases corrected the most common PAH disease variant (c.1222C>T, p.Arg408Trp) in a COS-7 cell model of PKU, restoring PAH enzymatic activity; the HDR enhancer RS-1 improved correction efficiency.","method":"FokI-dCas9 CRISPR genome editing with single-stranded oligodeoxynucleotide HDR template in PAH_c.1222C>T COS-7 cells; PAH enzymatic activity assay post-correction","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 1–2 / Weak — direct restoration of enzymatic activity confirmed in cell-based assay with genome editing, single lab study","pmids":["27786189"],"is_preprint":false},{"year":2020,"finding":"CRISPR/Cas9-mediated deletion of Pah exon 1 in mice produces animals that are homozygously null for both PAH protein expression and enzymatic activity in liver, resulting in severe hyperphenylalaninemia that accurately replicates classical PKU phenotype; null PAH monomers in existing models can form inhibitory heterotetramers with wild-type PAH, a confound eliminated in this model.","method":"CRISPR/Cas9 embryonic gene editing to delete Pah exon 1; liver PAH activity assay; plasma phenylalanine measurement; Western blot for PAH protein absence","journal":"Molecular genetics and metabolism","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct enzymatic and protein assays confirming complete loss of function; heterotetramer inhibition mechanism supported by activity rescue experiments implied by rationale for model design","pmids":["33051130"],"is_preprint":false},{"year":2016,"finding":"Chronic hyperphenylalaninemia in PAHenu2 mice causes extensive aberrant DNA methylation in brain tissue, including hypomethylation of miRNA genes within the imprinted Dlk1-Dio3 locus and hypermethylation of promoters of synaptic genes, leading to altered gene expression; dietary phenylalanine restriction attenuates this aberrant methylation pattern.","method":"Methylated DNA immunoprecipitation with paired-end sequencing (MeDIP-seq) in brain tissue of PAHenu2 mice under hyperphenylalaninemic or phenylalanine-restricted conditions; gene expression validation","journal":"Molecular genetics and metabolism","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genome-wide methylation sequencing with dietary manipulation in established mouse PKU model; phenylalanine as causal agent confirmed by rescue experiment","pmids":["26822703"],"is_preprint":false},{"year":2015,"finding":"PAH-deficient PKU patients exhibit altered DNA methylation patterns in brain tissue with downstream impact on gene expression, and in peripheral leukocytes with the degree of methylation alteration correlated with degree of phenylalanine exposure; noncoding RNA genes show extensive differential methylation in high-exposure patients.","method":"Methylated DNA immunoprecipitation with paired-end sequencing in brain tissue from classical PKU patients and leukocytes from well/poorly controlled PKU patients; expression analysis of differentially methylated genes in brain","journal":"Molecular genetics and metabolism","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — human tissue MeDIP-seq with expression validation; correlation with phenylalanine exposure level supports causality but is observational in human samples","pmids":["25990862"],"is_preprint":false}],"current_model":"Phenylalanine hydroxylase (PAH) is a homotetrameric liver enzyme (EC 1.14.16.1) that hydroxylates L-phenylalanine to tyrosine using molecular oxygen and the cofactor tetrahydrobiopterin (BH4); most disease-causing missense mutations act by inducing monomer misfolding and/or failure of tetramer assembly, triggering accelerated proteasomal degradation and reduced intracellular enzyme levels, while splice-site mutations can activate cryptic splice sites to produce frameshifted, truncated proteins, and chronic substrate accumulation (hyperphenylalaninemia) secondarily causes aberrant DNA methylation and altered gene expression in the brain."},"narrative":{"mechanistic_narrative":"Phenylalanine hydroxylase (PAH) is the enzyme that converts L-phenylalanine to tyrosine using molecular oxygen and the cofactor tetrahydrobiopterin (BH4), and its loss of function causes hyperphenylalaninemia and phenylketonuria (PKU) [PMID:17443661]. The dominant pathogenic mechanism is amino acid substitution-induced misfolding of the PAH monomer and/or failure to assemble into the native homotetramer, which accelerates cellular degradation and lowers steady-state enzyme levels, thereby reducing phenylalanine hydroxylation; residual in vitro activity of individual missense variants correlates with clinical metabolic severity [PMID:12655545, PMID:11708866]. Splice-site mutations constitute a distinct mechanism: disruption of an invariant intronic GT donor activates cryptic splice sites, generating frameshifted, prematurely truncated transcripts and PAH deficiency [PMID:11161825]. Complete loss of PAH protein and activity in liver reproduces classical PKU, and null monomers can form inhibitory heterotetramers with wild-type PAH [PMID:33051130]. Beyond the enzyme defect itself, the resulting chronic phenylalanine accumulation drives a secondary epigenetic consequence: aberrant DNA methylation and altered gene expression in brain tissue, including differential methylation of noncoding/miRNA and synaptic genes, with the degree of alteration tracking phenylalanine exposure and reversible by dietary phenylalanine restriction [PMID:26822703, PMID:25990862]. Genome-editing correction of the common p.Arg408Trp variant restores PAH enzymatic activity in a cellular model [PMID:27786189].","teleology":[{"year":2001,"claim":"Establishing that splice-site disruption is a mechanistically distinct route to PAH deficiency clarified that not all pathogenic alleles act through protein misfolding.","evidence":"cDNA and genomic sequencing of cryptic splice products in the PAHenu3 mouse model","pmids":["11161825"],"confidence":"Medium","gaps":["Does not quantify the relative contribution of splice-site versus missense mechanisms across the human allele spectrum","Cryptic-site usage characterized in mouse, not directly in human tissue"]},{"year":2001,"claim":"Direct expression of individual missense mutants quantified residual activity and linked it to clinical severity, grounding genotype-phenotype prediction.","evidence":"Eukaryotic expression (pCDNA3/COS-7) and enzymatic assay of L41F, T92I, P211T","pmids":["11708866"],"confidence":"Medium","gaps":["Only three variants tested in a single lab","Does not resolve whether reduced activity reflects misfolding, instability, or catalytic impairment"]},{"year":2003,"claim":"Systematic expression analysis across 81 mutations defined misfolding/failed tetramer assembly with accelerated degradation as the predominant disease mechanism, unifying many alleles under one model.","evidence":"In vitro expression in multiple eukaryotic cell systems with residual activity and protein-level quantification","pmids":["12655545"],"confidence":"High","gaps":["Cellular degradation pathway not defined at the molecular level in this study","Does not address in vivo enzyme stability in liver"]},{"year":2007,"claim":"Synthesis of decades of biochemistry consolidated the catalytic reaction, cofactor requirement, and the link of >500 loss-of-function alleles to hyperphenylalaninemia and PKU.","evidence":"Review integrating reconstituted enzymatic assays (EC 1.14.16.1) and genetic data","pmids":["17443661"],"confidence":"High","gaps":["Review-level synthesis rather than new primary experiment","Does not address tissue-specific or downstream consequences of substrate accumulation"]},{"year":2015,"claim":"Showing aberrant DNA methylation in PKU patient brain and leukocytes that scales with phenylalanine exposure introduced a secondary epigenetic mechanism downstream of the enzyme defect.","evidence":"MeDIP-seq of brain and leukocytes from classical/controlled PKU patients with expression analysis","pmids":["25990862"],"confidence":"Medium","gaps":["Human data are observational and correlational, not causal","Mechanism linking phenylalanine to methylation machinery not defined"]},{"year":2016,"claim":"Dietary rescue in the PAHenu2 mouse established phenylalanine itself as the causal driver of brain methylation changes, advancing the secondary mechanism from correlation toward causation.","evidence":"MeDIP-seq of brain under hyperphenylalaninemic versus phenylalanine-restricted diet with expression validation","pmids":["26822703"],"confidence":"Medium","gaps":["Molecular pathway by which phenylalanine alters methyltransferase activity unresolved","Functional/behavioral consequences of specific methylation changes not demonstrated"]},{"year":2016,"claim":"Genome-editing correction of the common p.Arg408Trp allele provided proof-of-concept that restoring the coding sequence recovers enzymatic activity.","evidence":"FokI-dCas9 editing with ssODN HDR template in c.1222C>T COS-7 cells; PAH activity assay","pmids":["27786189"],"confidence":"Medium","gaps":["Demonstrated only in a cell model, not in liver in vivo","Editing efficiency and off-target profile not therapeutically validated"]},{"year":2020,"claim":"A clean exon-1-deletion null mouse removed the confounding inhibitory heterotetramer effect, providing a definitive complete-loss-of-function PKU model.","evidence":"CRISPR/Cas9 embryonic deletion of Pah exon 1; liver activity, plasma phenylalanine, and Western blot","pmids":["33051130"],"confidence":"Medium","gaps":["Heterotetramer inhibition is inferred from model rationale rather than directly assayed here","Does not address residual-activity (hypomorphic) disease forms"]},{"year":null,"claim":"The molecular pathway connecting phenylalanine accumulation to the DNA methylation machinery, and the route from misfolded monomers to proteasomal degradation in vivo, remain unresolved.","evidence":"No timeline discovery defines these mechanistic links","pmids":[],"confidence":"Medium","gaps":["No mechanism linking substrate accumulation to methyltransferase activity","In vivo degradation pathway for misfolded PAH not characterized"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016491","term_label":"oxidoreductase activity","supporting_discovery_ids":[0,1,2]}],"localization":[],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0]}],"complexes":["PAH homotetramer"],"partners":[],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P00439","full_name":"Phenylalanine-4-hydroxylase","aliases":["Phe-4-monooxygenase"],"length_aa":452,"mass_kda":51.9,"function":"Catalyzes the hydroxylation of L-phenylalanine to L-tyrosine","subcellular_location":"","url":"https://www.uniprot.org/uniprotkb/P00439/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PAH","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/PAH","total_profiled":1310},"omim":[{"mim_id":"621248","title":"PULMONARY HYPERTENSION, PRIMARY, 7; PPH7","url":"https://www.omim.org/entry/621248"},{"mim_id":"619064","title":"MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 20; MC4DN20","url":"https://www.omim.org/entry/619064"},{"mim_id":"617384","title":"HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4","url":"https://www.omim.org/entry/617384"},{"mim_id":"613355","title":"CHROMOSOME 17q23.1-q23.2 DELETION SYNDROME","url":"https://www.omim.org/entry/613355"},{"mim_id":"612719","title":"6-@PYRUVOYL-TETRAHYDROPTERIN SYNTHASE; PTS","url":"https://www.omim.org/entry/612719"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Endoplasmic reticulum","reliability":"Approved"},{"location":"Vesicles","reliability":"Approved"}],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"kidney","ntpm":463.6},{"tissue":"liver","ntpm":1316.7}],"url":"https://www.proteinatlas.org/search/PAH"},"hgnc":{"alias_symbol":["PH"],"prev_symbol":[]},"alphafold":{"accession":"P00439","domains":[{"cath_id":"3.30.70.260","chopping":"34-118","consensus_level":"high","plddt":82.5533,"start":34,"end":118},{"cath_id":"1.10.800.10","chopping":"128-401","consensus_level":"high","plddt":95.2407,"start":128,"end":401},{"cath_id":"-","chopping":"409-450","consensus_level":"medium","plddt":87.7362,"start":409,"end":450}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P00439","model_url":"https://alphafold.ebi.ac.uk/files/AF-P00439-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P00439-F1-predicted_aligned_error_v6.png","plddt_mean":88.69},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PAH","jax_strain_url":"https://www.jax.org/strain/search?query=PAH"},"sequence":{"accession":"P00439","fasta_url":"https://rest.uniprot.org/uniprotkb/P00439.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P00439/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P00439"}},"corpus_meta":[{"pmid":"18329116","id":"PMC_18329116","title":"Real-Time PCR quantification of PAH-ring hydroxylating dioxygenase (PAH-RHDalpha) genes from Gram positive and Gram negative bacteria in soil and sediment samples.","date":"2008","source":"Journal of microbiological methods","url":"https://pubmed.ncbi.nlm.nih.gov/18329116","citation_count":263,"is_preprint":false},{"pmid":"22440811","id":"PMC_22440811","title":"Prenatal polycyclic aromatic hydrocarbon (PAH) exposure and child behavior at age 6-7 years.","date":"2012","source":"Environmental health perspectives","url":"https://pubmed.ncbi.nlm.nih.gov/22440811","citation_count":259,"is_preprint":false},{"pmid":"17443661","id":"PMC_17443661","title":"The PAH gene, phenylketonuria, and a paradigm shift.","date":"2007","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/17443661","citation_count":234,"is_preprint":false},{"pmid":"16291565","id":"PMC_16291565","title":"Polycyclic aromatic hydrocarbon (PAH) ecotoxicology in marine ecosystems.","date":"2006","source":"Journal of toxicology and environmental health. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/16291565","citation_count":213,"is_preprint":false},{"pmid":"23930949","id":"PMC_23930949","title":"pH- and ion-sensitive polymers for drug delivery.","date":"2013","source":"Expert opinion on drug delivery","url":"https://pubmed.ncbi.nlm.nih.gov/23930949","citation_count":196,"is_preprint":false},{"pmid":"27943120","id":"PMC_27943120","title":"Polycyclic aromatic hydrocarbons and PAH-related DNA adducts.","date":"2016","source":"Journal of applied genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27943120","citation_count":151,"is_preprint":false},{"pmid":"12227511","id":"PMC_12227511","title":"Profiles of PAH emission from steel and iron industries.","date":"2002","source":"Chemosphere","url":"https://pubmed.ncbi.nlm.nih.gov/12227511","citation_count":128,"is_preprint":false},{"pmid":"32506150","id":"PMC_32506150","title":"A comprehensive review of metabolic and genomic aspects of PAH-degradation.","date":"2020","source":"Archives of microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/32506150","citation_count":122,"is_preprint":false},{"pmid":"9950961","id":"PMC_9950961","title":"Cloning of the human kidney PAH transporter: narrow substrate specificity and regulation by protein kinase C.","date":"1999","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/9950961","citation_count":117,"is_preprint":false},{"pmid":"15504935","id":"PMC_15504935","title":"Contribution of multidrug resistance protein 2 (MRP2/ABCC2) to the renal excretion of p-aminohippurate (PAH) and identification of MRP4 (ABCC4) as a novel PAH transporter.","date":"2004","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/15504935","citation_count":114,"is_preprint":false},{"pmid":"19933154","id":"PMC_19933154","title":"A pH-responsive riboregulator.","date":"2009","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/19933154","citation_count":110,"is_preprint":false},{"pmid":"12472777","id":"PMC_12472777","title":"Urate transport via human PAH transporter hOAT1 and its gene structure.","date":"2003","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/12472777","citation_count":104,"is_preprint":false},{"pmid":"30200294","id":"PMC_30200294","title":"TGF-β and BMPR2 Signaling in PAH: Two Black Sheep in One Family.","date":"2018","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30200294","citation_count":101,"is_preprint":false},{"pmid":"30626738","id":"PMC_30626738","title":"Human PAH is characterized by a pattern of lipid-related insulin resistance.","date":"2019","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/30626738","citation_count":98,"is_preprint":false},{"pmid":"11369471","id":"PMC_11369471","title":"Interaction of PAH-related compounds with the alpha and beta isoforms of the estrogen receptor.","date":"2001","source":"Toxicology letters","url":"https://pubmed.ncbi.nlm.nih.gov/11369471","citation_count":96,"is_preprint":false},{"pmid":"9200857","id":"PMC_9200857","title":"Methods for routine biological monitoring of carcinogenic PAH-mixtures.","date":"1997","source":"The Science of the total environment","url":"https://pubmed.ncbi.nlm.nih.gov/9200857","citation_count":90,"is_preprint":false},{"pmid":"25349473","id":"PMC_25349473","title":"Resistant mutations in CML and Ph(+)ALL - role of ponatinib.","date":"2014","source":"Biologics : targets & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/25349473","citation_count":86,"is_preprint":false},{"pmid":"18294902","id":"PMC_18294902","title":"Mutagenicity and DNA adduct formation of PAH, nitro-PAH, and oxy-PAH fractions of atmospheric particulate matter from São Paulo, Brazil.","date":"2008","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/18294902","citation_count":85,"is_preprint":false},{"pmid":"21845152","id":"PMC_21845152","title":"Polycyclic aromatic hydrocarbon (PAH) exposure and DNA adduct semi-quantitation in archived human tissues.","date":"2011","source":"International journal of environmental research and public health","url":"https://pubmed.ncbi.nlm.nih.gov/21845152","citation_count":82,"is_preprint":false},{"pmid":"25658648","id":"PMC_25658648","title":"Bacterial PAH degradation in marine and terrestrial habitats.","date":"2015","source":"Current opinion in biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/25658648","citation_count":76,"is_preprint":false},{"pmid":"19633127","id":"PMC_19633127","title":"Influence of vegetation on the in situ bacterial community and polycyclic aromatic hydrocarbon (PAH) degraders in aged PAH-contaminated or thermal-desorption-treated soil.","date":"2009","source":"Applied and environmental microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/19633127","citation_count":76,"is_preprint":false},{"pmid":"34102054","id":"PMC_34102054","title":"Genetically Encoded, pH-Sensitive mTFP1 Biosensor for Probing Lysosomal pH.","date":"2021","source":"ACS sensors","url":"https://pubmed.ncbi.nlm.nih.gov/34102054","citation_count":64,"is_preprint":false},{"pmid":"7890802","id":"PMC_7890802","title":"Pleckstrin homology (PH) domains in signal transduction.","date":"1994","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7890802","citation_count":64,"is_preprint":false},{"pmid":"15192115","id":"PMC_15192115","title":"pH microdomains in oligodendrocytes.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15192115","citation_count":63,"is_preprint":false},{"pmid":"12655545","id":"PMC_12655545","title":"How PAH gene mutations cause hyper-phenylalaninemia and why mechanism matters: insights from in vitro expression.","date":"2003","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/12655545","citation_count":62,"is_preprint":false},{"pmid":"22496325","id":"PMC_22496325","title":"Plumbagin reverses proliferation and resistance to apoptosis in experimental PAH.","date":"2012","source":"The European respiratory journal","url":"https://pubmed.ncbi.nlm.nih.gov/22496325","citation_count":58,"is_preprint":false},{"pmid":"11807932","id":"PMC_11807932","title":"Cancer risk assessment for oral exposure to PAH mixtures.","date":"2002","source":"Journal of applied toxicology : JAT","url":"https://pubmed.ncbi.nlm.nih.gov/11807932","citation_count":52,"is_preprint":false},{"pmid":"33401039","id":"PMC_33401039","title":"Root exudates enhance the PAH degradation and degrading gene abundance in soils.","date":"2020","source":"The Science of the total environment","url":"https://pubmed.ncbi.nlm.nih.gov/33401039","citation_count":51,"is_preprint":false},{"pmid":"20204747","id":"PMC_20204747","title":"PDGF receptor and its antagonists: role in treatment of PAH.","date":"2010","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/20204747","citation_count":48,"is_preprint":false},{"pmid":"27123491","id":"PMC_27123491","title":"Synergism of FAK and tyrosine kinase inhibition in Ph+ B-ALL.","date":"2016","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/27123491","citation_count":48,"is_preprint":false},{"pmid":"17548691","id":"PMC_17548691","title":"Associations between smoking, polymorphisms in polycyclic aromatic hydrocarbon (PAH) metabolism and conjugation genes and PAH-DNA adducts in prostate tumors differ by race.","date":"2007","source":"Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/17548691","citation_count":48,"is_preprint":false},{"pmid":"10335444","id":"PMC_10335444","title":"Functions and transcriptional regulation of PAH-inducible human UDP-glucuronosyltransferases.","date":"1999","source":"Drug metabolism reviews","url":"https://pubmed.ncbi.nlm.nih.gov/10335444","citation_count":47,"is_preprint":false},{"pmid":"19440493","id":"PMC_19440493","title":"PAH-DNA adducts, cigarette smoking, GST polymorphisms, and breast cancer risk.","date":"2008","source":"Environmental health perspectives","url":"https://pubmed.ncbi.nlm.nih.gov/19440493","citation_count":47,"is_preprint":false},{"pmid":"32161260","id":"PMC_32161260","title":"Crystal structure of a lipin/Pah phosphatidic acid phosphatase.","date":"2020","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/32161260","citation_count":42,"is_preprint":false},{"pmid":"22198330","id":"PMC_22198330","title":"Environmental polycyclic aromatic hydrocarbon (PAH) exposure and DNA damage in Mexican children.","date":"2011","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/22198330","citation_count":41,"is_preprint":false},{"pmid":"31220749","id":"PMC_31220749","title":"Endocrine disruption and commensal bacteria alteration associated with gaseous and soil PAH contamination among daycare children.","date":"2019","source":"Environment international","url":"https://pubmed.ncbi.nlm.nih.gov/31220749","citation_count":40,"is_preprint":false},{"pmid":"26809239","id":"PMC_26809239","title":"BMPR2 gene therapy for PAH acts via Smad and non-Smad signalling.","date":"2016","source":"Respirology (Carlton, Vic.)","url":"https://pubmed.ncbi.nlm.nih.gov/26809239","citation_count":39,"is_preprint":false},{"pmid":"19849832","id":"PMC_19849832","title":"Evidence for the adaptation of protein pH-dependence to subcellular pH.","date":"2009","source":"BMC biology","url":"https://pubmed.ncbi.nlm.nih.gov/19849832","citation_count":39,"is_preprint":false},{"pmid":"15667104","id":"PMC_15667104","title":"Real-time visualization and quantification of PAH photodegradation on and within plant leaves.","date":"2005","source":"Environmental science & technology","url":"https://pubmed.ncbi.nlm.nih.gov/15667104","citation_count":39,"is_preprint":false},{"pmid":"6089881","id":"PMC_6089881","title":"Intracellular pH distribution and transmembrane pH profile of yeast cells.","date":"1984","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/6089881","citation_count":38,"is_preprint":false},{"pmid":"7539372","id":"PMC_7539372","title":"DNA dosimetry in biological indicator species living on PAH-contaminated soils and sediments.","date":"1995","source":"Ecotoxicology and environmental safety","url":"https://pubmed.ncbi.nlm.nih.gov/7539372","citation_count":37,"is_preprint":false},{"pmid":"34638915","id":"PMC_34638915","title":"miR-29a-3p/THBS2 Axis Regulates PAH-Induced Cardiac Fibrosis.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34638915","citation_count":36,"is_preprint":false},{"pmid":"29550714","id":"PMC_29550714","title":"Phototoxic effects of PAH and UVA exposure on molecular responses and developmental success in coral larvae.","date":"2018","source":"Aquatic toxicology (Amsterdam, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/29550714","citation_count":36,"is_preprint":false},{"pmid":"28789461","id":"PMC_28789461","title":"Clinical significance of circulating microparticles in Ph- myeloproliferative neoplasms.","date":"2017","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/28789461","citation_count":36,"is_preprint":false},{"pmid":"9972476","id":"PMC_9972476","title":"Cytochrome P450 and dependent activities in unexposed and PAH-exposed terrestrial annelids.","date":"1998","source":"Comparative biochemistry and physiology. Part C, Pharmacology, toxicology & endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/9972476","citation_count":35,"is_preprint":false},{"pmid":"24120886","id":"PMC_24120886","title":"Anthropometric characteristics and nutrition in a cohort of PAH-deficient patients.","date":"2013","source":"Clinical nutrition (Edinburgh, Scotland)","url":"https://pubmed.ncbi.nlm.nih.gov/24120886","citation_count":35,"is_preprint":false},{"pmid":"11727930","id":"PMC_11727930","title":"pH and chemotherapy.","date":"2001","source":"Novartis Foundation symposium","url":"https://pubmed.ncbi.nlm.nih.gov/11727930","citation_count":34,"is_preprint":false},{"pmid":"26689975","id":"PMC_26689975","title":"BMPR2 gene delivery reduces mutation-related PAH and counteracts TGF-β-mediated pulmonary cell signalling.","date":"2015","source":"Respirology (Carlton, Vic.)","url":"https://pubmed.ncbi.nlm.nih.gov/26689975","citation_count":34,"is_preprint":false},{"pmid":"16705750","id":"PMC_16705750","title":"Subcellular pH and predicted pH-dependent features of proteins.","date":"2006","source":"Proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/16705750","citation_count":34,"is_preprint":false},{"pmid":"16914451","id":"PMC_16914451","title":"Molecular characterization of Sin3 PAH-domain interactor specificity and identification of PAH partners.","date":"2006","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/16914451","citation_count":34,"is_preprint":false},{"pmid":"32385190","id":"PMC_32385190","title":"Fluorene exposure among PAH-exposed workers is associated with epigenetic markers related to lung cancer.","date":"2020","source":"Occupational and environmental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32385190","citation_count":33,"is_preprint":false},{"pmid":"19268543","id":"PMC_19268543","title":"Polymorphisms in SLC6A4, PAH, GABRB3, and MAOB and modification of psychotic disorder features.","date":"2009","source":"Schizophrenia research","url":"https://pubmed.ncbi.nlm.nih.gov/19268543","citation_count":33,"is_preprint":false},{"pmid":"34818449","id":"PMC_34818449","title":"The LPS induced pyroptosis exacerbates BMPR2 signaling deficiency to potentiate SLE-PAH.","date":"2021","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/34818449","citation_count":32,"is_preprint":false},{"pmid":"18985011","id":"PMC_18985011","title":"Mutation analysis of PAH gene and characterization of a recurrent deletion mutation in Korean patients with phenylketonuria.","date":"2008","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/18985011","citation_count":32,"is_preprint":false},{"pmid":"25863187","id":"PMC_25863187","title":"Prenatal polycyclic aromatic hydrocarbon (PAH) exposure, antioxidant levels and behavioral development of children ages 6-9.","date":"2015","source":"Environmental research","url":"https://pubmed.ncbi.nlm.nih.gov/25863187","citation_count":32,"is_preprint":false},{"pmid":"20621368","id":"PMC_20621368","title":"Expression of CYP1C1 and CYP1A in Fundulus heteroclitus during PAH-induced carcinogenesis.","date":"2010","source":"Aquatic toxicology (Amsterdam, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/20621368","citation_count":30,"is_preprint":false},{"pmid":"31767312","id":"PMC_31767312","title":"Current situation of polycyclic aromatic hydrocarbons (PAH) in PM2.5 in a receptor site in Mexico City and estimation of carcinogenic PAH by combining non-real-time and real-time measurement techniques.","date":"2019","source":"The Science of the total environment","url":"https://pubmed.ncbi.nlm.nih.gov/31767312","citation_count":30,"is_preprint":false},{"pmid":"28086156","id":"PMC_28086156","title":"Effects of different agricultural wastes on the dissipation of PAHs and the PAH-degrading genes in a PAH-contaminated soil.","date":"2017","source":"Chemosphere","url":"https://pubmed.ncbi.nlm.nih.gov/28086156","citation_count":30,"is_preprint":false},{"pmid":"33374819","id":"PMC_33374819","title":"Novel Advances in Modifying BMPR2 Signaling in PAH.","date":"2020","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/33374819","citation_count":29,"is_preprint":false},{"pmid":"31331330","id":"PMC_31331330","title":"Revealing the pathogenic changes of PAH based on multiomics characteristics.","date":"2019","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31331330","citation_count":28,"is_preprint":false},{"pmid":"9016524","id":"PMC_9016524","title":"The PAH mutation analysis consortium database: update 1996.","date":"1997","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/9016524","citation_count":28,"is_preprint":false},{"pmid":"32176619","id":"PMC_32176619","title":"RNA sequencing analysis of monocrotaline-induced PAH reveals dysregulated chemokine and neuroactive ligand receptor pathways.","date":"2020","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/32176619","citation_count":26,"is_preprint":false},{"pmid":"22539616","id":"PMC_22539616","title":"Contributions of aryl hydrocarbon receptor genetic variants to the risk of glioma and PAH-DNA adducts.","date":"2012","source":"Toxicological sciences : an official journal of the Society of Toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/22539616","citation_count":26,"is_preprint":false},{"pmid":"31812113","id":"PMC_31812113","title":"Assessment of the toxicity of firefighter exposures using the PAH CALUX bioassay.","date":"2019","source":"Environment international","url":"https://pubmed.ncbi.nlm.nih.gov/31812113","citation_count":26,"is_preprint":false},{"pmid":"11727927","id":"PMC_11727927","title":"pH, hypoxia and metastasis.","date":"2001","source":"Novartis Foundation symposium","url":"https://pubmed.ncbi.nlm.nih.gov/11727927","citation_count":25,"is_preprint":false},{"pmid":"30019447","id":"PMC_30019447","title":"The underestimated role of basophils in Ph+ chronic myeloid leukaemia.","date":"2018","source":"European journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/30019447","citation_count":25,"is_preprint":false},{"pmid":"29233926","id":"PMC_29233926","title":"Targeting CDK6 and BCL2 Exploits the \"MYB Addiction\" of Ph+ Acute Lymphoblastic Leukemia.","date":"2017","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/29233926","citation_count":25,"is_preprint":false},{"pmid":"22140629","id":"PMC_22140629","title":"Idiopathic and heritable PAH perturb common molecular pathways, correlated with increased MSX1 expression.","date":"2011","source":"Pulmonary circulation","url":"https://pubmed.ncbi.nlm.nih.gov/22140629","citation_count":25,"is_preprint":false},{"pmid":"25990862","id":"PMC_25990862","title":"Altered DNA methylation in PAH deficient phenylketonuria.","date":"2015","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/25990862","citation_count":24,"is_preprint":false},{"pmid":"31095595","id":"PMC_31095595","title":"Assessment of arsenic and polycyclic aromatic hydrocarbon (PAH) exposures on immune function among males in Bangladesh.","date":"2019","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/31095595","citation_count":23,"is_preprint":false},{"pmid":"25908611","id":"PMC_25908611","title":"Mechanism-Based Classification of PAH Mixtures to Predict Carcinogenic Potential.","date":"2015","source":"Toxicological sciences : an official journal of the Society of Toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/25908611","citation_count":22,"is_preprint":false},{"pmid":"26365998","id":"PMC_26365998","title":"Dual pH- and Temperature-Responsive Protein Nanoparticles.","date":"2015","source":"European polymer journal","url":"https://pubmed.ncbi.nlm.nih.gov/26365998","citation_count":21,"is_preprint":false},{"pmid":"27786189","id":"PMC_27786189","title":"CRISPR RNA-guided FokI nucleases repair a PAH variant in a phenylketonuria model.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27786189","citation_count":21,"is_preprint":false},{"pmid":"18294361","id":"PMC_18294361","title":"A mutation analysis of the phenylalanine hydroxylase (PAH) gene in the Israeli population.","date":"2008","source":"Annals of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18294361","citation_count":21,"is_preprint":false},{"pmid":"15987477","id":"PMC_15987477","title":"Chondrocytes, synoviocytes and dermal fibroblasts all express PH-20, a hyaluronidase active at neutral pH.","date":"2005","source":"Arthritis research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/15987477","citation_count":21,"is_preprint":false},{"pmid":"36534359","id":"PMC_36534359","title":"Bacterial degradation of mixed-PAHs and expression of PAH-catabolic genes.","date":"2022","source":"World journal of microbiology & biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/36534359","citation_count":20,"is_preprint":false},{"pmid":"22366298","id":"PMC_22366298","title":"Dual therapy in IPAH and SSc-PAH. A qualitative systematic review.","date":"2012","source":"Respiratory medicine","url":"https://pubmed.ncbi.nlm.nih.gov/22366298","citation_count":20,"is_preprint":false},{"pmid":"22940734","id":"PMC_22940734","title":"Microbial diversity and PAH catabolic genes tracking spatial heterogeneity of PAH concentrations.","date":"2012","source":"Microbial ecology","url":"https://pubmed.ncbi.nlm.nih.gov/22940734","citation_count":20,"is_preprint":false},{"pmid":"37122013","id":"PMC_37122013","title":"Polycyclic aromatic hydrocarbon (PAH) biodegradation capacity revealed by a genome-function relationship approach.","date":"2023","source":"Environmental microbiome","url":"https://pubmed.ncbi.nlm.nih.gov/37122013","citation_count":20,"is_preprint":false},{"pmid":"26822703","id":"PMC_26822703","title":"DNA methylation in the pathophysiology of hyperphenylalaninemia in the PAH(enu2) mouse model of phenylketonuria.","date":"2016","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/26822703","citation_count":20,"is_preprint":false},{"pmid":"24401910","id":"PMC_24401910","title":"The mutation spectrum of the phenylalanine hydroxylase (PAH) gene and associated haplotypes reveal ethnic heterogeneity in the Taiwanese population.","date":"2014","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24401910","citation_count":20,"is_preprint":false},{"pmid":"6844913","id":"PMC_6844913","title":"DNA damage by PAH and repair in a marine sponge.","date":"1983","source":"The Science of the total environment","url":"https://pubmed.ncbi.nlm.nih.gov/6844913","citation_count":19,"is_preprint":false},{"pmid":"9781015","id":"PMC_9781015","title":"Mutation at the phenylalanine hydroxylase gene (PAH) and its use to document population genetic variation: the Quebec experience.","date":"1998","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/9781015","citation_count":19,"is_preprint":false},{"pmid":"16404638","id":"PMC_16404638","title":"Decreasing urinary PAH metabolites and 7-methylguanine after smoking cessation.","date":"2006","source":"International archives of occupational and environmental health","url":"https://pubmed.ncbi.nlm.nih.gov/16404638","citation_count":19,"is_preprint":false},{"pmid":"29470642","id":"PMC_29470642","title":"Real-World Switching to Riociguat: Management and Practicalities in Patients with PAH and CTEPH.","date":"2018","source":"Lung","url":"https://pubmed.ncbi.nlm.nih.gov/29470642","citation_count":17,"is_preprint":false},{"pmid":"32418891","id":"PMC_32418891","title":"\"Real life\" polycyclic aromatic hydrocarbon (PAH) mixtures modulate hCG, hPL and hPLGF levels and disrupt the physiological ratio of MMP-2 to MMP-9 and VEGF expression in human placenta cell lines.","date":"2020","source":"Reproductive toxicology (Elmsford, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/32418891","citation_count":17,"is_preprint":false},{"pmid":"29749107","id":"PMC_29749107","title":"Mutation analysis of the PAH gene in phenylketonuria patients from Rio de Janeiro, Southeast Brazil.","date":"2018","source":"Molecular genetics & genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29749107","citation_count":15,"is_preprint":false},{"pmid":"38547751","id":"PMC_38547751","title":"PAH bioremediation with Rhodococcus rhodochrous ATCC 21198: Impact of cell immobilization and surfactant use on PAH treatment and post-remediation toxicity.","date":"2024","source":"Journal of hazardous materials","url":"https://pubmed.ncbi.nlm.nih.gov/38547751","citation_count":15,"is_preprint":false},{"pmid":"38354516","id":"PMC_38354516","title":"Th17/IL-17A axis is critical for pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc): SSc patients with high levels of serum IL-17A exhibit reduced lung functions and increased prevalence of PAH.","date":"2024","source":"Cytokine","url":"https://pubmed.ncbi.nlm.nih.gov/38354516","citation_count":15,"is_preprint":false},{"pmid":"16050139","id":"PMC_16050139","title":"PAH- and PCB-induced alterations of protein tyrosine kinase and cytokine gene transcription in harbor seal (Phoca vitulina) PBMC.","date":"2005","source":"Clinical & developmental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/16050139","citation_count":15,"is_preprint":false},{"pmid":"11708866","id":"PMC_11708866","title":"PAH gene mutations in the Sicilian population: association with minihaplotypes and expression analysis.","date":"2001","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/11708866","citation_count":15,"is_preprint":false},{"pmid":"1385300","id":"PMC_1385300","title":"Linkage relations between A2M, HOX3, INT1, KRAS2, and PAH on bovine chromosome 5.","date":"1992","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/1385300","citation_count":15,"is_preprint":false},{"pmid":"30747360","id":"PMC_30747360","title":"Mutation spectrum of PAH gene in phenylketonuria patients in Northwest China: identification of twenty novel variants.","date":"2019","source":"Metabolic brain disease","url":"https://pubmed.ncbi.nlm.nih.gov/30747360","citation_count":14,"is_preprint":false},{"pmid":"28566433","id":"PMC_28566433","title":"mTORC1 Inhibition Induces Resistance to Methotrexate and 6-Mercaptopurine in Ph+ and Ph-like B-ALL.","date":"2017","source":"Molecular cancer therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/28566433","citation_count":13,"is_preprint":false},{"pmid":"31369996","id":"PMC_31369996","title":"Filaggrin variations are associated with PAH metabolites in urine and DNA alterations in blood.","date":"2019","source":"Environmental research","url":"https://pubmed.ncbi.nlm.nih.gov/31369996","citation_count":13,"is_preprint":false},{"pmid":"32650165","id":"PMC_32650165","title":"Cell-by-cell estimation of PAH sorption and subsequent toxicity in marine phytoplankton.","date":"2020","source":"Chemosphere","url":"https://pubmed.ncbi.nlm.nih.gov/32650165","citation_count":13,"is_preprint":false},{"pmid":"11161825","id":"PMC_11161825","title":"Characterization of the mouse phenylalanine hydroxylase mutation Pah(enu3).","date":"2001","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/11161825","citation_count":13,"is_preprint":false},{"pmid":"34865703","id":"PMC_34865703","title":"Has Ph-like ALL Superseded Ph+ ALL as the Least Favorable Subtype?","date":"2021","source":"Best practice & research. Clinical haematology","url":"https://pubmed.ncbi.nlm.nih.gov/34865703","citation_count":12,"is_preprint":false},{"pmid":"33051130","id":"PMC_33051130","title":"A novel Pah-exon1 deleted murine model of phenylalanine hydroxylase (PAH) deficiency.","date":"2020","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/33051130","citation_count":12,"is_preprint":false},{"pmid":"37377741","id":"PMC_37377741","title":"Advances in PAH mixture toxicology enabled by zebrafish.","date":"2023","source":"Current opinion in toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/37377741","citation_count":12,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":52531,"output_tokens":2856,"usd":0.100217,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9293,"output_tokens":2653,"usd":0.056395,"stage2_stop_reason":"end_turn"},"total_usd":0.156612,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"Looking through the 100 abstracts, I need to identify which ones are about the canonical human PAH gene (phenylalanine hydroxylase, EC 1.14.16.1) that causes phenylketonuria when mutated.\n\nPapers about the canonical PAH gene (phenylalanine hydroxylase):\n- [3] Scriver CR, 2007 - overview of PAH gene/PKU\n- [25] Waters PJ, 2003 - in vitro expression analysis of PAH mutations\n- [34] Khayyo et al, 2020 - crystal structure of lipin/Pah PAP (this is a DIFFERENT protein - lipin phosphatidic acid phosphatase, not phenylalanine hydroxylase)\n- [46] Aldámiz-Echevarría, 2013 - PAH-deficient patients nutrition\n- [52] Bergen SE, 2009 - PAH microsatellite association with schizophrenia symptoms\n- [54] Lee YW, 2008 - PAH gene mutation analysis Korean PKU\n- [61] Nowacki, 1997 - PAH mutation database\n- [69] Dobrowolski, 2015 - DNA methylation in PAH deficiency\n- [73] Pan Y, 2016 - CRISPR correction of PAH variant\n- [74] Bercovich, 2008 - PAH mutation analysis Israeli population\n- [80] Dobrowolski, 2016 - DNA methylation in PAHenu2 mouse model\n- [81] Liang Y, 2014 - PAH mutation spectrum Taiwan\n- [83] Carter KC, 1998 - PAH mutations Quebec\n- [87] Vieira Neto, 2018 - PAH mutations Brazil\n- [91] Mirisola, 2001 - PAH mutations Sicilian, expression analysis\n- [92] Barendse, 1992 - linkage on bovine chromosome 5\n- [93] Yan Y, 2019 - PAH mutations Northwest China\n- [97] Haefele, 2001 - mouse Pahenu3 characterization\n- [99] Richards, 2020 - novel Pah-exon1 deleted mouse model\n\nPapers with actual mechanistic findings about PAH (phenylalanine hydroxylase):\n- [3]: PAH enzyme converts phenylalanine to tyrosine with O2 and BH4 cofactor - this is established biochemistry referenced\n- [25]: In vitro expression analysis establishing misfolding/aggregation/degradation mechanism\n- [73]: CRISPR correction restoring PAH activity in COS-7 cell model\n- [91]: In vitro expression of missense mutations showing residual activities\n- [97]: Mouse splice site mutation creating aberrant transcripts\n- [99]: CRISPR/Cas9 mouse model lacking PAH activity/protein\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2007,\n      \"finding\": \"PAH enzyme (phenylalanine hydroxylase) catalyzes the conversion of L-phenylalanine to tyrosine in the presence of molecular oxygen and the nonprotein cofactor tetrahydrobiopterin (BH4); loss-of-function mutations (>500 alleles) in the PAH gene cause hyperphenylalaninemia and phenylketonuria.\",\n      \"method\": \"Review synthesizing established biochemical assays and genetic studies; enzymatic activity (EC 1.14.16.1) documented across decades of in vitro and in vivo work\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — enzymatic mechanism reconstituted and replicated across many independent laboratories over decades; cofactor requirements established by in vitro assay\",\n      \"pmids\": [\"17443661\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"In vitro expression analysis of 81 PAH mutations established that the predominant pathogenic mechanism is amino acid substitution-induced misfolding of the PAH monomer and/or failure to assemble into the native homotetramer, leading to accelerated cellular degradation and reduced intracellular steady-state enzyme levels, thereby decreasing phenylalanine hydroxylation.\",\n      \"method\": \"In vitro expression in multiple eukaryotic cell systems (COS-7 and others), quantification of residual enzyme activity and protein levels for 81 distinct PAH missense and other mutations\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — direct in vitro expression assays with multiple mutations across multiple systems, replicated across independent labs summarized in curated database\",\n      \"pmids\": [\"12655545\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"In vitro eukaryotic expression (pCDNA3/COS-7 system) of three PAH missense mutations (L41F, T92I, P211T) demonstrated residual PAH enzyme activities of 10%, 76%, and 72% of normal, respectively, confirming their pathogenicity and establishing a correlation between in vitro residual activity and clinical metabolic phenotype severity.\",\n      \"method\": \"Eukaryotic expression system (pCDNA3/COS-7), enzymatic activity assay for mutant PAH proteins\",\n      \"journal\": \"Molecular genetics and metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — direct in vitro enzymatic assay with mutagenesis, but single lab with limited number of mutations\",\n      \"pmids\": [\"11708866\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"A splice-site mutation at the invariant GT dinucleotide of the exon 11 intron 11 boundary (T→G transversion, equivalent to human c.1199+2T>G) in the mouse Pah gene ablates normal splicing and activates two cryptic splice donor sites, generating transcripts with a 5-nt insertion or 5-nt deletion that cause frameshifting in exons 12–13 and premature termination, resulting in PAH deficiency.\",\n      \"method\": \"cDNA sequencing of mutant transcripts, genomic sequencing of splice site, characterization of aberrant splicing products in PAHenu3 mouse model\",\n      \"journal\": \"Molecular genetics and metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct sequencing of mutant allele and transcripts with identification of cryptic splice sites; functional consequence (hyperphenylalaninemia) confirmed in vivo in mouse model\",\n      \"pmids\": [\"11161825\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"CRISPR RNA-guided FokI-dCas9 nucleases corrected the most common PAH disease variant (c.1222C>T, p.Arg408Trp) in a COS-7 cell model of PKU, restoring PAH enzymatic activity; the HDR enhancer RS-1 improved correction efficiency.\",\n      \"method\": \"FokI-dCas9 CRISPR genome editing with single-stranded oligodeoxynucleotide HDR template in PAH_c.1222C>T COS-7 cells; PAH enzymatic activity assay post-correction\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Weak — direct restoration of enzymatic activity confirmed in cell-based assay with genome editing, single lab study\",\n      \"pmids\": [\"27786189\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"CRISPR/Cas9-mediated deletion of Pah exon 1 in mice produces animals that are homozygously null for both PAH protein expression and enzymatic activity in liver, resulting in severe hyperphenylalaninemia that accurately replicates classical PKU phenotype; null PAH monomers in existing models can form inhibitory heterotetramers with wild-type PAH, a confound eliminated in this model.\",\n      \"method\": \"CRISPR/Cas9 embryonic gene editing to delete Pah exon 1; liver PAH activity assay; plasma phenylalanine measurement; Western blot for PAH protein absence\",\n      \"journal\": \"Molecular genetics and metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct enzymatic and protein assays confirming complete loss of function; heterotetramer inhibition mechanism supported by activity rescue experiments implied by rationale for model design\",\n      \"pmids\": [\"33051130\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Chronic hyperphenylalaninemia in PAHenu2 mice causes extensive aberrant DNA methylation in brain tissue, including hypomethylation of miRNA genes within the imprinted Dlk1-Dio3 locus and hypermethylation of promoters of synaptic genes, leading to altered gene expression; dietary phenylalanine restriction attenuates this aberrant methylation pattern.\",\n      \"method\": \"Methylated DNA immunoprecipitation with paired-end sequencing (MeDIP-seq) in brain tissue of PAHenu2 mice under hyperphenylalaninemic or phenylalanine-restricted conditions; gene expression validation\",\n      \"journal\": \"Molecular genetics and metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genome-wide methylation sequencing with dietary manipulation in established mouse PKU model; phenylalanine as causal agent confirmed by rescue experiment\",\n      \"pmids\": [\"26822703\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"PAH-deficient PKU patients exhibit altered DNA methylation patterns in brain tissue with downstream impact on gene expression, and in peripheral leukocytes with the degree of methylation alteration correlated with degree of phenylalanine exposure; noncoding RNA genes show extensive differential methylation in high-exposure patients.\",\n      \"method\": \"Methylated DNA immunoprecipitation with paired-end sequencing in brain tissue from classical PKU patients and leukocytes from well/poorly controlled PKU patients; expression analysis of differentially methylated genes in brain\",\n      \"journal\": \"Molecular genetics and metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — human tissue MeDIP-seq with expression validation; correlation with phenylalanine exposure level supports causality but is observational in human samples\",\n      \"pmids\": [\"25990862\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"Phenylalanine hydroxylase (PAH) is a homotetrameric liver enzyme (EC 1.14.16.1) that hydroxylates L-phenylalanine to tyrosine using molecular oxygen and the cofactor tetrahydrobiopterin (BH4); most disease-causing missense mutations act by inducing monomer misfolding and/or failure of tetramer assembly, triggering accelerated proteasomal degradation and reduced intracellular enzyme levels, while splice-site mutations can activate cryptic splice sites to produce frameshifted, truncated proteins, and chronic substrate accumulation (hyperphenylalaninemia) secondarily causes aberrant DNA methylation and altered gene expression in the brain.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"Phenylalanine hydroxylase (PAH) is the enzyme that converts L-phenylalanine to tyrosine using molecular oxygen and the cofactor tetrahydrobiopterin (BH4), and its loss of function causes hyperphenylalaninemia and phenylketonuria (PKU) [#0]. The dominant pathogenic mechanism is amino acid substitution-induced misfolding of the PAH monomer and/or failure to assemble into the native homotetramer, which accelerates cellular degradation and lowers steady-state enzyme levels, thereby reducing phenylalanine hydroxylation; residual in vitro activity of individual missense variants correlates with clinical metabolic severity [#1, #2]. Splice-site mutations constitute a distinct mechanism: disruption of an invariant intronic GT donor activates cryptic splice sites, generating frameshifted, prematurely truncated transcripts and PAH deficiency [#3]. Complete loss of PAH protein and activity in liver reproduces classical PKU, and null monomers can form inhibitory heterotetramers with wild-type PAH [#5]. Beyond the enzyme defect itself, the resulting chronic phenylalanine accumulation drives a secondary epigenetic consequence: aberrant DNA methylation and altered gene expression in brain tissue, including differential methylation of noncoding/miRNA and synaptic genes, with the degree of alteration tracking phenylalanine exposure and reversible by dietary phenylalanine restriction [#6, #7]. Genome-editing correction of the common p.Arg408Trp variant restores PAH enzymatic activity in a cellular model [#4].\",\n  \"teleology\": [\n    {\n      \"year\": 2001,\n      \"claim\": \"Establishing that splice-site disruption is a mechanistically distinct route to PAH deficiency clarified that not all pathogenic alleles act through protein misfolding.\",\n      \"evidence\": \"cDNA and genomic sequencing of cryptic splice products in the PAHenu3 mouse model\",\n      \"pmids\": [\"11161825\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Does not quantify the relative contribution of splice-site versus missense mechanisms across the human allele spectrum\", \"Cryptic-site usage characterized in mouse, not directly in human tissue\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Direct expression of individual missense mutants quantified residual activity and linked it to clinical severity, grounding genotype-phenotype prediction.\",\n      \"evidence\": \"Eukaryotic expression (pCDNA3/COS-7) and enzymatic assay of L41F, T92I, P211T\",\n      \"pmids\": [\"11708866\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Only three variants tested in a single lab\", \"Does not resolve whether reduced activity reflects misfolding, instability, or catalytic impairment\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Systematic expression analysis across 81 mutations defined misfolding/failed tetramer assembly with accelerated degradation as the predominant disease mechanism, unifying many alleles under one model.\",\n      \"evidence\": \"In vitro expression in multiple eukaryotic cell systems with residual activity and protein-level quantification\",\n      \"pmids\": [\"12655545\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cellular degradation pathway not defined at the molecular level in this study\", \"Does not address in vivo enzyme stability in liver\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Synthesis of decades of biochemistry consolidated the catalytic reaction, cofactor requirement, and the link of >500 loss-of-function alleles to hyperphenylalaninemia and PKU.\",\n      \"evidence\": \"Review integrating reconstituted enzymatic assays (EC 1.14.16.1) and genetic data\",\n      \"pmids\": [\"17443661\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Review-level synthesis rather than new primary experiment\", \"Does not address tissue-specific or downstream consequences of substrate accumulation\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Showing aberrant DNA methylation in PKU patient brain and leukocytes that scales with phenylalanine exposure introduced a secondary epigenetic mechanism downstream of the enzyme defect.\",\n      \"evidence\": \"MeDIP-seq of brain and leukocytes from classical/controlled PKU patients with expression analysis\",\n      \"pmids\": [\"25990862\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Human data are observational and correlational, not causal\", \"Mechanism linking phenylalanine to methylation machinery not defined\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Dietary rescue in the PAHenu2 mouse established phenylalanine itself as the causal driver of brain methylation changes, advancing the secondary mechanism from correlation toward causation.\",\n      \"evidence\": \"MeDIP-seq of brain under hyperphenylalaninemic versus phenylalanine-restricted diet with expression validation\",\n      \"pmids\": [\"26822703\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular pathway by which phenylalanine alters methyltransferase activity unresolved\", \"Functional/behavioral consequences of specific methylation changes not demonstrated\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Genome-editing correction of the common p.Arg408Trp allele provided proof-of-concept that restoring the coding sequence recovers enzymatic activity.\",\n      \"evidence\": \"FokI-dCas9 editing with ssODN HDR template in c.1222C>T COS-7 cells; PAH activity assay\",\n      \"pmids\": [\"27786189\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Demonstrated only in a cell model, not in liver in vivo\", \"Editing efficiency and off-target profile not therapeutically validated\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"A clean exon-1-deletion null mouse removed the confounding inhibitory heterotetramer effect, providing a definitive complete-loss-of-function PKU model.\",\n      \"evidence\": \"CRISPR/Cas9 embryonic deletion of Pah exon 1; liver activity, plasma phenylalanine, and Western blot\",\n      \"pmids\": [\"33051130\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Heterotetramer inhibition is inferred from model rationale rather than directly assayed here\", \"Does not address residual-activity (hypomorphic) disease forms\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The molecular pathway connecting phenylalanine accumulation to the DNA methylation machinery, and the route from misfolded monomers to proteasomal degradation in vivo, remain unresolved.\",\n      \"evidence\": \"No timeline discovery defines these mechanistic links\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No mechanism linking substrate accumulation to methyltransferase activity\", \"In vivo degradation pathway for misfolded PAH not characterized\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016491\", \"supporting_discovery_ids\": [0, 1, 2]}\n    ],\n    \"localization\": [],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"complexes\": [\"PAH homotetramer\"],\n    \"partners\": [],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"faith_supported":6,"faith_total":6,"faith_pct":100.0}}